Open Access
Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery
Karol A Biernacki
1
,
Mateusz Daśko
2
,
Olga Ciupak
1
,
Konrad Kubiński
3
,
Janusz Rachon
1
,
Sebastian Demkowicz
1
Publication type: Journal Article
Publication date: 2020-05-29
PubMed ID:
32485996
Drug Discovery
Pharmaceutical Science
Molecular Medicine
Abstract
Five-membered 1,2,4-oxadiazole heterocyclic ring has received considerable attention because of its unique bioisosteric properties and an unusually wide spectrum of biological activities. Thus, it is a perfect framework for the novel drug development. After a century since the 1,2,4-oxadiazole have been discovered, the uncommon potential attracted medicinal chemists’ attention, leading to the discovery of a few presently accessible drugs containing 1,2,4-oxadiazole unit. It is worth noting that the interest in a 1,2,4-oxadiazoles’ biological application has been doubled in the last fifteen years. Herein, after a concise historical introduction, we present a comprehensive overview of the recent achievements in the synthesis of 1,2,4-oxadiazole-based compounds and the major advances in their biological applications in the period of the last five years as well as brief remarks on prospects for further development.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
|
|
|
Journal of Molecular Structure
13 publications, 9.03%
|
|
|
ChemistrySelect
7 publications, 4.86%
|
|
|
Results in Chemistry
5 publications, 3.47%
|
|
|
Molecules
4 publications, 2.78%
|
|
|
Russian Journal of General Chemistry
4 publications, 2.78%
|
|
|
International Journal of Molecular Sciences
4 publications, 2.78%
|
|
|
Molecular Diversity
4 publications, 2.78%
|
|
|
Journal of Enzyme Inhibition and Medicinal Chemistry
4 publications, 2.78%
|
|
|
Bioorganic Chemistry
3 publications, 2.08%
|
|
|
Chemistry and Biodiversity
3 publications, 2.08%
|
|
|
Journal of Medicinal Chemistry
3 publications, 2.08%
|
|
|
Tetrahedron Letters
2 publications, 1.39%
|
|
|
Journal of Heterocyclic Chemistry
2 publications, 1.39%
|
|
|
Journal of Chemical Research
2 publications, 1.39%
|
|
|
Medicinal Chemistry Research
2 publications, 1.39%
|
|
|
ACS Omega
2 publications, 1.39%
|
|
|
Journal of Saudi Chemical Society
2 publications, 1.39%
|
|
|
Tetrahedron
2 publications, 1.39%
|
|
|
European Journal of Medicinal Chemistry
2 publications, 1.39%
|
|
|
Advanced Synthesis and Catalysis
2 publications, 1.39%
|
|
|
Angewandte Chemie
2 publications, 1.39%
|
|
|
Angewandte Chemie - International Edition
2 publications, 1.39%
|
|
|
Archiv der Pharmazie
2 publications, 1.39%
|
|
|
ChemMedChem
2 publications, 1.39%
|
|
|
Polycyclic Aromatic Compounds
2 publications, 1.39%
|
|
|
RSC Medicinal Chemistry
2 publications, 1.39%
|
|
|
Asian Journal of Chemistry
2 publications, 1.39%
|
|
|
Journal of Organic Chemistry
2 publications, 1.39%
|
|
|
Synthetic Communications
2 publications, 1.39%
|
|
|
2
4
6
8
10
12
14
|
Publishers
|
5
10
15
20
25
30
35
|
|
|
Elsevier
32 publications, 22.22%
|
|
|
Wiley
27 publications, 18.75%
|
|
|
Springer Nature
14 publications, 9.72%
|
|
|
MDPI
13 publications, 9.03%
|
|
|
American Chemical Society (ACS)
12 publications, 8.33%
|
|
|
Taylor & Francis
10 publications, 6.94%
|
|
|
Pleiades Publishing
5 publications, 3.47%
|
|
|
Bentham Science Publishers Ltd.
5 publications, 3.47%
|
|
|
Royal Society of Chemistry (RSC)
5 publications, 3.47%
|
|
|
Cold Spring Harbor Laboratory
4 publications, 2.78%
|
|
|
King Saud University
3 publications, 2.08%
|
|
|
SAGE
2 publications, 1.39%
|
|
|
Asian Journal of Chemistry
2 publications, 1.39%
|
|
|
Public Library of Science (PLoS)
2 publications, 1.39%
|
|
|
Frontiers Media S.A.
1 publication, 0.69%
|
|
|
Pharmaceutical Society of Korea
1 publication, 0.69%
|
|
|
Hindawi Limited
1 publication, 0.69%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.69%
|
|
|
Taras Shevchenko National University of Kyiv
1 publication, 0.69%
|
|
|
Georg Thieme Verlag KG
1 publication, 0.69%
|
|
|
Beilstein-Institut
1 publication, 0.69%
|
|
|
5
10
15
20
25
30
35
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
144
Total citations:
144
Citations from 2024:
61
(42.36%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Biernacki K. A. et al. Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery // Pharmaceuticals. 2020. Vol. 13. No. 6. p. 111.
GOST all authors (up to 50)
Copy
Biernacki K. A., Daśko M., Ciupak O., Kubiński K., Rachon J., Demkowicz S. Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery // Pharmaceuticals. 2020. Vol. 13. No. 6. p. 111.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3390/ph13060111
UR - https://doi.org/10.3390/ph13060111
TI - Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery
T2 - Pharmaceuticals
AU - Biernacki, Karol A
AU - Daśko, Mateusz
AU - Ciupak, Olga
AU - Kubiński, Konrad
AU - Rachon, Janusz
AU - Demkowicz, Sebastian
PY - 2020
DA - 2020/05/29
PB - MDPI
SP - 111
IS - 6
VL - 13
PMID - 32485996
SN - 1424-8247
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Biernacki,
author = {Karol A Biernacki and Mateusz Daśko and Olga Ciupak and Konrad Kubiński and Janusz Rachon and Sebastian Demkowicz},
title = {Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery},
journal = {Pharmaceuticals},
year = {2020},
volume = {13},
publisher = {MDPI},
month = {may},
url = {https://doi.org/10.3390/ph13060111},
number = {6},
pages = {111},
doi = {10.3390/ph13060111}
}
Cite this
MLA
Copy
Biernacki, Karol A., et al. “Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery.” Pharmaceuticals, vol. 13, no. 6, May. 2020, p. 111. https://doi.org/10.3390/ph13060111.